ASND
Featured PickAscendis Pharma A/S
Real picks. Real tracking. We bet on one stock daily and show you exactly how it plays out.
AI Confidence Score
85
Entry Price
$241.71
Current Price
$38.74
Total Return
+0.00%
vs SPY
+0.00%
As of Close 2026-04-15
Executive Summary
Ascendis Pharma (ASND) is primed for a major momentum breakout following a fresh BofA Securities price target hike to $292, driven by robust Yorvipath sales and over 5,400 U.S. prescriptions written since launch. This fundamental validation acts as an immediate catalyst to push the stock through near-term resistance into blue-sky territory. The setup perfectly aligns with today's Risk-On, earnings-driven market regime, where stable volatility and abundant liquidity aggressively reward fundamental outperformance and momentum continuation.
Technical Context
Setup
ASND is flashing a confirmed breakout setup with a strong 15.5 confluence score, trading just 3.3% below its 52-week high with a 6.0% 20-day return on healthy 1.2x relative volume.
Invalidation (Stop)
The bullish thesis is invalidated if the stock breaks below its key structural support at $215.54.
Runner-ups
Recent Performance History
49 Total Picks • 56% Win Rate (7d)
| Date | Ticker | Entry | Last | Gain/Loss | 7d | 30d | 60d |
|---|---|---|---|---|---|---|---|
| 2026-04-13 | ASND | $248.55 | $241.71 | -2.75% | N/A | N/A | N/A |
| 2026-04-10 | DBRG | $15.55 | $15.59 | +0.26% | N/A | N/A | N/A |
| 2026-04-09 | PKBK | $29.80 | $29.51 | -0.97% | N/A | N/A | N/A |
| 2026-04-08 | PKBK | $29.15 | $29.51 | +1.23% | +1.23% | N/A | N/A |
| 2026-04-07 | FOLD | $14.47 | $14.46 | -0.07% | -0.07% | N/A | N/A |
| 2026-04-06 | ROL | $54.13 | $54.38 | +0.46% | +0.98% | N/A | N/A |
| 2026-04-02 | DAR | $64.65 | $58.44 | -9.61% | -5.12% | N/A | N/A |
| 2026-04-01 | FOLD | $14.44 | $14.46 | +0.14% | +0.14% | N/A | N/A |
| 2026-03-31 | TKO | $201.65 | $193.10 | -4.24% | -2.30% | N/A | N/A |
| 2026-03-30 | TKO | $195.41 | $193.10 | -1.18% | +0.82% | N/A | N/A |
Schema v1.0 | Pipeline v1.2.0